Given the apparent outcome it seems you are correct and we are stuck with 'snail-mail' progress while potentially competitive therapies (that are possibly standalone) are no doubt being developed... including the use of stem cells and perhaps even 3D printing of pancreas and/or stomach.
Regarding further CR this might be of interest - Gastrointestinal average cost Phase 2 trial USD $15.8M
https://www.centerpointclinicalserv...-access-part-1-clinical-trial-cost-breakdown/
so perhaps another $7-10m will do it!
Cheers
Given the apparent outcome it seems you are correct and we are...
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
7.0¢ |
Change
-0.001(1.41%) |
Mkt cap ! $512.3M | |||
| Open | High | Low | Value | Volume |
| 7.0¢ | 7.1¢ | 6.8¢ | $922.0K | 13.28M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 9 | 702419 | 7.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 7.1¢ | 1365317 | 9 |
View Market Depth
| Last trade - 16.10pm 24/05/2024 (20 minute delay) ? |
|
|||||
|
Last
7.0¢ |
Change
-0.001 ( 1.69 %) |
||||
| Open | High | Low | Volume | ||
| 7.0¢ | 7.1¢ | 6.8¢ | 5455105 | ||
| Last updated 15.59pm 24/05/2024 ? | |||||
| IMU (ASX) Chart |